Article
Dynamic Changes in the Gut Microbiota Composition during Adalimumab Therapy in Patients with Ulcerative Colitis: Implications for Treatment Response Prediction and Therapeutic Targets
2024-02-19
Abstract excerpt
<title>Abstract</title> <p>Background Little is known about the changes in the gut microbiota composition during anti-tumor necrosis factor-alpha (anti TNF-α) therapy. This study aimed to investigate the dynamics of gut microbiome changes during anti TNF-α (adalimumab) therapy in patients with ulcerative colitis (UC). Results The microbiota composition was affected by the disease severity and extent in patients...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0fd7310d-757c-58b8-a905-b6a47f639993
- DOI
- 10.21203/rs.3.rs-3957225/v1
